Picture of Aurobindo Pharma logo

AUROPHARMA Aurobindo Pharma Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-1.81%
3m-7.76%
6m+3.62%
1yr+58.85%
Volume Change (%)
10d/3m-27.74%
Price vs... (%)
52w High-13.36%
50d MA-3.81%
200d MA+9.84%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.95
PEG Ratio (f)0.93
EPS Growth (f)20.75%
Dividend Yield (f)0.5%
Valuation (ttm)IndustryMarket
Price to Book Value2.12
Price to Tang. Book2.45
Price to Free Cashflown/a
Price to Sales2.14
EV to EBITDA11.68

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.44%
Return on Equity10.32%
Operating Margin12.68%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueIN₹m195,635.5230,985.1247,746.2234,554.9248,553.8286,773.45314,345.248.54%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+0.47+18.23+17.28-18.07-30.38+61.46+20.25n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Aurobindo Pharma EPS forecast chart

Profile Summary

Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals and related services. Its product portfolio is spread over seven therapeutic/product areas encompassing Central nervous systems (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Orals & Sterile, Anti-infectives, Anti-diabetics and Cephalosporins - Orals. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. It is also developing about three depot injections based on the microsphere and nano-suspension technology platforms. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited, and others.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 26th, 1986
Public Since
January 19th, 1995
No. of Shareholders
343,617
No. of Employees
15,690
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconNational Stock Exchange of India
Shares in Issue
585,938,609

AUROPHARMA Share Price Performance

Upcoming Events for AUROPHARMA

Q4 2024 Aurobindo Pharma Ltd Earnings Release

Q1 2025 Aurobindo Pharma Ltd Earnings Release

Similar to AUROPHARMA

Picture of Aarey Drugs and Pharmaceuticals logo

Aarey Drugs and Pharmaceuticals

in flag iconNational Stock Exchange of India

Picture of Aarti Drugs logo

Aarti Drugs

in flag iconNational Stock Exchange of India

Picture of Aarti Pharmalabs logo

Aarti Pharmalabs

in flag iconNational Stock Exchange of India

Picture of Abbott India logo

Abbott India

in flag iconNational Stock Exchange of India

Picture of Accent Microcell logo

Accent Microcell

in flag iconNational Stock Exchange of India

FAQ